Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02774850 · ClinicalTrials.gov registry record
Home Away From Home - Medical Outcomes
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 610
- Enrollment target
NCT02774850: Completed study, sponsored by Children's Hospital of Philadelphia.
NCT02774850 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 610 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02774850 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 610 participants
- Enrollment target
Study Summary
Treatment for pediatric acute myeloid leukemia (AML) involves intensive chemotherapy regimens that result in periods of profound neutropenia leaving patients susceptible to severe infectious complications. Infectious complications are the leading cause of treatment related mortality among AML patients, but there are little clinical data to inform whether management of neutropenia post AML chemotherapy should occur in an outpatient or inpatient setting. The primary objective of this study is to compare the clinical effectiveness of outpatient versus inpatient management of neutropenia in children with AML.
Primary Outcome
Identification of bacteremia will begin three days after completion of a chemotherapy course and will continue until recovery of absolute neutrophil count (ANC \> 200 uL), or until the start of the next course (for a very small number of patients who begin the next course of chemotherapy prior to count recovery). Bacteremia will be defined as a single positive blood culture for a bacterial pathogen (including Viridans group Streptococci). If the bacterium is an organism considered as a common co
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 610 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-07-26 |
What the finished NCT02774850 record still lists
NCT02774850 is an observational study that tracks outcomes without assigning an intervention. The registered 610 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02774850 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02774850 about?
NCT02774850 is a clinical study titled "Home Away From Home - Medical Outcomes". Treatment for pediatric acute myeloid leukemia (AML) involves intensive chemotherapy regimens that result in periods of profound neutropenia leaving patients susceptible to severe infectious complications. Infectious complications are the leading cause of treatment related mortality among AML patien...
What is the current status of trial NCT02774850?
This trial is currently completed. The enrollment target is 610 participants. The study started on 2015-06. Estimated completion is 2019-07-26.
Who is sponsoring clinical trial NCT02774850?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03536312 · 610 participants · NA
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
- NCT05838638 · 610 participants · NA
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
- NCT07075718 · 610 participants · Phase 2
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- NCT00823654 · 609 participants
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia